January 2021 – Policy & Medicine

Insys Therapeutics Founder Settles with the State of New Jersey Over Role in Opioid Epidemic

AMA to Advocate for Telemedicine Access, Even After COVID-19

PhRMA Announces Principles on Clinical Trial Diversity

Final Rule Released on the 340B Dispute Process

CMS Updates Guidance on Sunshine Act Reporting Thresholds for 2021

ACCME Releases 2019 Data Report

California Genetic Testing Lab Resolves False Claims Act Allegations

OPDP Sends Six Warning and Untitled Letters in 2020 – Final Letter Sent to Azurity Pharmaceuticals

FDA Finalizes Guidance Regarding Complex Products Meetings

FDA Releases Draft Question and Answers Guidance on Interchangeable Products